ABHD5 and Hepatic steatosis: Histological analysis confirmed the ameliorative effect of intestinal ATGL/CGI-58 deficiency on hepatic steatosis (Figure 2D), which might be attributable to 48% decreased plasma TG levels in the VLDL fraction (Figures 2E and 2F).